Synergistic inhibition of colon cancer growth by the combination of methylglyoxal and silencing of glyoxalase I mediated by the STAT1 pathway

Methylglyoxal (MG), an extremely reactive glucose metabolite, exhibits antitumor activity. Glyoxalase I (GLOI), which catalyzes MG metabolism, is associated with the progression of human malignancies. While the roles of MG or GLOI have been demonstrated in some types of cancer, their effects in colo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Chen, Yuan, Fang, Lei, Li, Gefei, Zhang, Jiali, Li, Changxi, Ma, Mengni, Guan, Chen, Bai, Fumao, Lyu, Jianxin, Meng, Qing H.
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5589625/
https://ncbi.nlm.nih.gov/pubmed/28903386
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.18601
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars